Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen, Kite Pharma ink deal to develop cancer immunotherapies

[Reuters] – Amgen Inc and Kite Pharma Inc said they entered into a deal to develop and market cancer immunotherapies using Amgen’s cancer targets and Kite’s technology platform. Amgen will pay Kite Pharma . . . → Read More: Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen, Kite Pharma ink deal to develop cancer immunotherapies Similar Articles: Company Update: Amgen Inc (NASDAQ:AMGN) – Actress Adamari López And Amgen Launch Spanish-Language Chemotherapy: Myths Or Facts™ Website And Resources Stock Update (NASDAQ:AMGN): The Amgen Foundation Expands Amgen Scholars Program to 17 Top Educational Institutions Worldwide Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen ovarian cancer drug fails to improve overall survival